Non human primate models for Alzheimer’s disease-related research and drug discovery
暂无分享,去创建一个
[1] Ü. Korkmaz,et al. Experimental Models in Neurodegenerative Diseases , 2019, Nuclear Medicine Seminars.
[2] Daniela Perani,et al. Faculty Opinions recommendation of Imaging markers for Alzheimer disease: which vs how. , 2017 .
[3] P. Naudé,et al. Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies? , 2016, Current Alzheimer research.
[4] M. Carrillo,et al. Challenges, solutions, and recommendations for Alzheimer's disease combination therapy , 2016, Alzheimer's & Dementia.
[5] Marc Tessier-Lavigne,et al. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9 , 2016, Nature.
[6] Y. Niu,et al. Genome editing in nonhuman primates: approach to generating human disease models , 2016, Journal of internal medicine.
[7] G. Howell,et al. Toward more predictive genetic mouse models of Alzheimer's disease , 2016, Brain Research Bulletin.
[8] L. Schneider,et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society , 2016, The Lancet Neurology.
[9] R. Vandenberghe,et al. Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT , 2016, Front. Pharmacol..
[10] P. Hof,et al. Early Alzheimer's disease–type pathology in the frontal cortex of wild mountain gorillas (Gorilla beringei beringei) , 2016, Neurobiology of Aging.
[11] D. Munoz,et al. Opportunities and challenges in developing relevant animal models for Alzheimer’s disease , 2016, Ageing Research Reviews.
[12] V. Yong,et al. Immunosenescence of microglia and macrophages: impact on the ageing central nervous system. , 2016, Brain : a journal of neurology.
[13] Tadlock Cowan,et al. The Animal Welfare Act: Background and Selected Animal Welfare Legislation , 2016 .
[14] Yonglun Luo,et al. Genetically modified pig models for neurodegenerative disorders , 2016, The Journal of pathology.
[15] J. Uslaner,et al. The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys , 2015, The Journal of Pharmacology and Experimental Therapeutics.
[16] J. Kaiser. BIOMEDICAL RESEARCH. An end to U.S. chimp research. , 2015, Science.
[17] S. Reardon. NIH to retire all research chimpanzees , 2015, Nature.
[18] M. Prince,et al. World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends , 2015 .
[19] J. Uslaner,et al. Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey , 2015, Psychopharmacology.
[20] A. Gjedde,et al. Amyloid Beta1–42 and the Phoshorylated Tau Threonine 231 in Brains of Aged Cynomolgus Monkeys (Macaca fascicularis) , 2014, Front. Aging Neurosci..
[21] Brian C Coe,et al. Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates , 2014, The Journal of Neuroscience.
[22] William D Hopkins,et al. Why primate models matter , 2014, American journal of primatology.
[23] Allen F. Brooks,et al. High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection. , 2014, ACS chemical neuroscience.
[24] B. Hooshmand,et al. Advances in the prevention of Alzheimer's disease and dementia , 2014, Journal of internal medicine.
[25] Patrick R Hof,et al. Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla) , 2013, The Journal of comparative neurology.
[26] J. Rilling,et al. Brain aging in humans, chimpanzees (Pan troglodytes), and rhesus macaques (Macaca mulatta): magnetic resonance imaging studies of macro- and microstructural changes , 2013, Neurobiology of Aging.
[27] Bill Y. Lin,et al. Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care , 2013, Neuroscience & Biobehavioral Reviews.
[28] Henry Brodaty,et al. Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future , 2013, Alzheimer's & Dementia.
[29] T. Hedden,et al. Meta-analysis of amyloid-cognition relations in cognitively normal older adults , 2013, Neurology.
[30] J. Tanji,et al. Goal-oriented, flexible use of numerical operations by monkeys , 2013, Animal Cognition.
[31] S. Everling,et al. Monkey in the middle: why non-human primates are needed to bridge the gap in resting-state investigations , 2012, Front. Neuroanat..
[32] A. Verkhratsky,et al. The serotonergic system in ageing and Alzheimer's disease , 2012, Progress in Neurobiology.
[33] M. Álvarez,et al. ¿Existe la enfermedad de Alzheimer en todos los primates? Afección de Alzheimer en primates no humanos y sus implicaciones fisiopatológicas (I) , 2012 .
[34] C. I. Fernández-Verdecia,et al. [Does Alzheimer's disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications (I)]. , 2012, Neurologia.
[35] Sterling C. Johnson,et al. Homocysteine, neural atrophy, and the effect of caloric restriction in rhesus monkeys , 2012, Neurobiology of Aging.
[36] Nick C Fox,et al. Brain imaging in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[37] Guojun Bu,et al. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[38] E. Heuer,et al. Nonhuman primate models of Alzheimer-like cerebral proteopathy. , 2012, Current pharmaceutical design.
[39] B. Strooper,et al. The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.
[40] C. Finch,et al. Primate aging in the mammalian scheme: the puzzle of extreme variation in brain aging , 2012, AGE.
[41] D. Van Dam,et al. Animal models in the drug discovery pipeline for Alzheimer's disease , 2011, British journal of pharmacology.
[42] David S. Miller,et al. Neuropsychiatric symptoms in Alzheimer’s disease , 2011, Alzheimer's & Dementia.
[43] M. J. Prescott,et al. Ethics of primate use , 2010, Advances in science and research.
[44] S. Kügler,et al. Alzheimer's disease: old problem, new views from transgenic and viral models. , 2010, Biochimica et biophysica acta.
[45] Mathias Jucker,et al. The benefits and limitations of animal models for translational research in neurodegenerative diseases , 2010, Nature Medicine.
[46] Wende Li,et al. A nonhuman primate model of Alzheimer’s disease generated by intracranial injection of amyloid-beta42 and thiorphan , 2010, Metabolic Brain Disease.
[47] T. Guilarte. APLP1, Alzheimer's-like pathology and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. , 2010, Neurotoxicology.
[48] I. Messaoudi,et al. Immune senescence in aged nonhuman primates , 2010, Experimental Gerontology.
[49] R. Schreiber,et al. Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials. , 2010, Current opinion in investigational drugs.
[50] A. Simon,et al. Acute γ-Secretase Inhibition of Nonhuman Primate CNS Shifts Amyloid Precursor Protein (APP) Metabolism from Amyloid-β Production to Alternative APP Fragments without Amyloid-β Rebound , 2010, The Journal of Neuroscience.
[51] K. Hashimoto,et al. In Vivo Evaluation of α7 Nicotinic Acetylcholine Receptor Agonists [11C]A-582941 and [11C]A-844606 in Mice and Conscious Monkeys , 2010, PloS one.
[52] G. Weinbauer,et al. Developmental and reproductive toxicology studies in nonhuman primates. , 2009, Birth defects research. Part B, Developmental and reproductive toxicology.
[53] J. Yesavage,et al. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.
[54] Pedro Pesini,et al. Natural Non-Trasgenic Animal Models for Research in Alzheimer’s Disease , 2009, Current Alzheimer research.
[55] F. LaFerla,et al. M1 agonists as a potential disease-modifying therapy for Alzheimer's disease. , 2009, Current Alzheimer research.
[56] D. Geschwind,et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease , 2009, Nature Medicine.
[57] Alison R. Gregro,et al. First Demonstration of Cerebrospinal Fluid and Plasma Aβ Lowering with Oral Administration of a β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor in Nonhuman Primates , 2009, Journal of Pharmacology and Experimental Therapeutics.
[58] Giovanni Coppola,et al. Tauopathy with paired helical filaments in an aged chimpanzee , 2008, The Journal of comparative neurology.
[59] A. Fisher. Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer’s disease , 2008, Neurotherapeutics.
[60] J. Bertranpetit,et al. Neuropathologic Findings in an Aged Albino Gorilla , 2008, Veterinary pathology.
[61] J. Bachevalier,et al. Towards a transgenic model of Huntington’s disease in a non-human primate , 2008, Nature.
[62] K. Becker,et al. Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese‐exposed non‐human primates , 2008, Journal of neurochemistry.
[63] A. Peters,et al. Synapses are lost during aging in the primate prefrontal cortex , 2008, Neuroscience.
[64] J. Capitanio,et al. Contributions of non-human primates to neuroscience research , 2008, The Lancet.
[65] Demao Chen,et al. Alzheimer's Disease (AD)-Like Pathology in Aged Monkeys after Infantile Exposure to Environmental Metal Lead (Pb): Evidence for a Developmental Origin and Environmental Link for AD , 2008, The Journal of Neuroscience.
[66] T. Horvath,et al. Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque , 2007, Neurobiology of Aging.
[67] E. Weerts,et al. The value of nonhuman primates in drug abuse research. , 2007, Experimental and clinical psychopharmacology.
[68] Patrick R Hof,et al. Changes in the structural complexity of the aged brain , 2007, Aging cell.
[69] Simon Festing,et al. The ethics of animal research , 2007, EMBO reports.
[70] J. Kirkwood. The Use of Non-Human Primates in Research , 2007, Animal Welfare.
[71] Y. Smith,et al. Cerebral beta-amyloid angiopathy in aged squirrel monkeys. , 2007, Histology and histopathology.
[72] Peter Paul De Deyn,et al. Model organisms: Drug discovery in dementia: the role of rodent models , 2006, Nature Reviews Drug Discovery.
[73] J. Lamb,et al. Characterisation of the binding of amyloid imaging tracers to rodent Aβ fibrils and rodent-human Aβ co-polymers , 2006 .
[74] Bryan L. Roth,et al. WAY-100635 is a potent dopamine D4 receptor agonist , 2006, Psychopharmacology.
[75] C. Lemere,et al. Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans. , 2006, Rejuvenation research.
[76] T. Casoli,et al. Synaptic pathology in the brain cortex of old monkeys as an early alteration in senile plaque formation. , 2006, Rejuvenation research.
[77] E. Mori,et al. What Constitutes Clinical Evidence for Neuroprotection in Alzheimer Disease: Support for the Cholinesterase Inhibitors? , 2006, Alzheimer disease and associated disorders.
[78] H. Braak,et al. The development of amyloid beta protein deposits in the aged brain. , 2006, Science of aging knowledge environment : SAGE KE.
[79] J. Rilling. Human and nonhuman primate brains: Are they allometrically scaled versions of the same design? , 2006 .
[80] S. DeKosky,et al. Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain , 2005, The Journal of Neuroscience.
[81] Nick C Fox,et al. Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial , 2005, Neurology.
[82] Jie Xu,et al. Specific humoral immune responses in rhesus monkeys vaccinated with the Alzheimer's disease-associated beta-amyloid 1-15 peptide vaccine. , 2005, Chinese medical journal.
[83] Michael V. Green,et al. PET imaging of brain with the β-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[84] R. Basha,et al. The Fetal Basis of Amyloidogenesis: Exposure to Lead and Latent Overexpression of Amyloid Precursor Protein and β-Amyloid in the Aging Brain , 2005, The Journal of Neuroscience.
[85] A. Brooks,et al. Encyclopedia of Human Evolution and Prehistory : Second Edition , 2004 .
[86] S. Gandy,et al. Toward modeling hemorrhagic and encephalitic complications of Alzheimer amyloid-beta vaccination in nonhuman primates. , 2004, Current opinion in immunology.
[87] Steven J Schapiro,et al. Use of primates in research: A global overview , 2004, American journal of primatology.
[88] R. Caspari,et al. Older age becomes common late in human evolution. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[89] N. Herrmann,et al. GABAergic Function in Alzheimer's Disease: Evidence for Dysfunction and Potential as a Therapeutic Target for the Treatment of Behavioural and Psychological Symptoms of Dementia , 2004, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[90] Frank R. Ervin,et al. Alzheimer's Disease Aβ Vaccine Reduces Central Nervous System Aβ Levels in a Non-Human Primate, the Caribbean Vervet , 2004 .
[91] D. Holtzman,et al. Alzheimer’s Aβ vaccination of rhesus monkeys (Macaca mulatta) , 2004, Mechanisms of Ageing and Development.
[92] I. Ferrer,et al. Neuropathology and Pathogenesis of Encephalitis following Amyloid β Immunization in Alzheimer's Disease , 2004, Brain pathology.
[93] G. Higgins,et al. Transgenic mouse models of Alzheimer's disease: phenotype and application , 2003, Behavioural pharmacology.
[94] B. Dubois,et al. Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization , 2003, Neurology.
[95] S. D. Preston,et al. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid β from the human brain , 2003, Neuropathology and applied neurobiology.
[96] C. Holmes,et al. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report , 2003, Nature Medicine.
[97] E. Fuchs,et al. Preservation of hippocampal neuron numbers in aged rhesus monkeys , 2003, Neurobiology of Aging.
[98] C. Geula,et al. Distribution, progression and chemical composition of cortical amyloid-β deposits in aged rhesus monkeys: similarities to the human , 2003, Acta Neuropathologica.
[99] D. Westaway,et al. Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4–10 and inhibit cytotoxicity and fibrillogenesis , 2002, Nature Medicine.
[100] J. Dodart,et al. Does my mouse have Alzheimer's disease? , 2002, Genes, brain, and behavior.
[101] P. Hof,et al. Comparative Neuropathology of Brain Aging in Primates , 2002 .
[102] Patrick R Hof,et al. Morphological alterations in neurons forming corticocortical projections in the neocortex of aged Patas monkeys , 2002, Neuroscience Letters.
[103] R. Nitsch,et al. Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.
[104] J. Hardy,et al. Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.
[105] B Frangione,et al. Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. , 2001, The American journal of pathology.
[106] M. Staufenbiel,et al. Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains* , 2001, The Journal of Biological Chemistry.
[107] A. Peters,et al. The effects of aging on layer 1 of primary visual cortex in the rhesus monkey. , 2001, Cerebral cortex.
[108] J. Hardy,et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease , 2000, Nature.
[109] Ralph A. Nixon,et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease , 2000, Nature.
[110] D. Selkoe,et al. Nasal Aβ Treatment Induces Anti‐Aβ Antibody Production and Decreases Cerebral Amyloid Burden in PD‐APP Mice , 2000 .
[111] H. Braak,et al. Age-related progression of tau pathology in brains of baboons , 2000, Neurobiology of Aging.
[112] R. Ridley,et al. The 5-HT1A antagonist, WAY 100 635, alleviates cognitive impairments induced by dizocilpine (MK-801) in monkeys , 2000, Neuropharmacology.
[113] F. Gage,et al. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[114] R. Motter,et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.
[115] M. Callahan. Combining tacrine with milameline reverses a scopolamine-induced impairment of continuous performance in rhesus monkeys , 1999, Psychopharmacology.
[116] Voytko Ml,et al. Nonhuman primates as models for aging and Alzheimer's disease. , 1998 .
[117] Rebecca K. Smith,et al. Primate Conservation , 1998, Folia Primatologica.
[118] T. Kemper,et al. Lack of correlation between plaque burden and cognition in the aged monkey , 1997, Acta Neuropathologica.
[119] L. Walker,et al. Animal models of cerebral β-amyloid angiopathy , 1997, Brain Research Reviews.
[120] H. Mori,et al. Characterization of amyloid β protein species in cerebral amyloid angiopathy of a squirrel monkey by immunocytochemistry and enzyme-linked immunosorbent assay , 1997, Brain Research.
[121] C. Bouras,et al. Quantitative analysis of tau protein-immunoreactive accumulations and β amyloid protein deposits in the cerebral cortex of the mouse lemur, Microcebus murinus , 1997, Acta Neuropathologica.
[122] R. Killiany,et al. Age-related neuronal loss in the nucleus centralis superior of the rhesus monkey , 1997, Acta Neuropathologica.
[123] J. Tigges,et al. β-Amyloid (Aβ) Deposition in the Brains of Aged Orangutans , 1997, Neurobiology of Aging.
[124] R F Thompson,et al. Memory systems in the brain and localization of a memory. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[125] Marla Gearing,et al. Aβ 40 is a major form of β-amyloid in nonhuman primates , 1996, Neurobiology of Aging.
[126] J. Gulcher,et al. Molecular Evolution of τ Protein: Implications for Alzheimer's Disease , 1996 .
[127] A. Calenda,et al. β-Amyloid Protein Precursor inMicrocebus murinus:Genotyping and Brain Localization , 1996, Neurobiology of Disease.
[128] F. Gage,et al. Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. , 1996, Gene therapy.
[129] H. Uno,et al. Cerebral amyloid angiopathy and plaques, and visceral amyloidosis in aged macaques , 1996, Neurobiology of Aging.
[130] M. Gearing,et al. Aβ‐peptide length aid apolipoprotein E genotype in Alzheimer's disease , 1996 .
[131] Jeffrey L. Cummings,et al. The spectrum of behavioral changes in Alzheimer's disease , 1996, Neurology.
[132] L. Walker,et al. β-Amyloid precursor protein gene in squirrel monkeys with cerebral amyloid angiopathy , 1995, Neurobiology of Aging.
[133] D. Price,et al. Neuronal number and size are preserved in the nucleus basalis of aged rhesus monkeys. , 1995, Dementia.
[134] B T Hyman,et al. Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[135] J. Morrison,et al. Apolipoprotein E-immunoreactivity in aged rhesus monkey cortex: Colocalization with amyloid plaques , 1994, Neurobiology of Aging.
[136] P Alvarez,et al. Memory consolidation and the medial temporal lobe: a simple network model. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[137] B T Hyman,et al. Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys. , 1994, The American journal of pathology.
[138] A. Smith,et al. Negative symptoms in schizophrenia: assessment of the effect of risperidone. , 1994 .
[139] D. Selkoe,et al. Identification of amyloid beta protein in the brain of the small, short-lived Lemurian primate Microcebus murinus , 1994, Neurobiology of Aging.
[140] D. Rosene. Comparing age-related changes in the basal forebrain and hippocampus of the rhesus monkey , 1993, Neurobiology of Aging.
[141] T. Kemper. The relationship of cerebral cortical changes to nuclei in the brainstem , 1993, Neurobiology of Aging.
[142] W. Benzing,et al. Galanin immunoreactivity within the primate basal forebrain: Evolutionary change between monkeys and apes , 1993, The Journal of comparative neurology.
[143] W. J. Jackson,et al. Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by young and aged monkeys. , 1993, Cerebral cortex.
[144] S. Gupta,et al. Toward a definite diagnosis of Alzheimer's disease. , 1992, Comprehensive psychiatry.
[145] D. Amaral,et al. Cholinergic cell loss and hypertrophy in the medial septal nucleus of the behaviorally characterized aged rhesus monkey , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[146] L. Squire. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. , 1992, Psychological review.
[147] N. Bons,et al. Senile plaques and neurofibrillary changes in the brain of an aged lemurian primate, Microcebus murinus , 1992, Neurobiology of Aging.
[148] L. Squire,et al. The medial temporal lobe memory system , 1991, Science.
[149] D. Price,et al. Aged Non‐Human Primates: An Animal Model of Age‐Associated Neurodegenerative Disease , 1991, Brain pathology.
[150] D. Selkoe,et al. Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease. , 1991, The American journal of pathology.
[151] J L McGaugh,et al. The role of interactions between the cholinergic system and other neuromodulatory systems in learing and memory , 1991, Synapse.
[152] R. Levy,et al. Accuracy of clinical diagnosis of Alzheimer's disease. , 1990, BMJ.
[153] S. Rapoport. Integrated phylogeny of the primate brain, with special reference to humans and their diseases , 1990, Brain Research Reviews.
[154] E. Mufson,et al. Galanin‐like immunoreactivity within the primate basal forebrain: Differential staining patterns between humans and monkeys , 1990, The Journal of comparative neurology.
[155] K. Marotti,et al. Nucleotide sequence of the cynomolgus monkey apolipoprotein E cDNA. , 1989, Nucleic acids research.
[156] J. Hixson,et al. The baboon apolipoprotein E gene: structure, expression, and linkage with the gene for apolipoprotein C-1. , 1988, Genomics.
[157] M. Mishkin,et al. Age differences in recognition memory of the rhesus monkey (Macaca mulatta) , 1987, Neurobiology of Aging.
[158] S H Ferris,et al. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. , 1987, The Journal of clinical psychiatry.
[159] J. Breslow,et al. Plasma and hepatic apoE isoproteins of nonhuman primates. Differences in apoE among humans, apes, and New and Old World monkeys. , 1985, Journal of lipid research.
[160] D. Price,et al. Neurobiological Studies of Transmitter Systems in Aging and in Alzheimer‐Type Dementia a , 1985, Annals of the New York Academy of Sciences.
[161] E. Uemura. Age-related changes in the subiculum of Macaca mulatta: Synaptic density , 1985, Experimental Neurology.
[162] E. Uemura,et al. Age-related changes in prefrontal cortex of Macaca mulatta: Quantitative analysis of dendritic branching patterns , 1980, Experimental Neurology.
[163] R. Bartus,et al. Localization of cellular changes within multimodal sensory regions in aged monkey brain: Possible implications for age-related cognitive loss , 1980, Neurobiology of Aging.
[164] W. Niklowitz,et al. Neurofibrillary changes following childhood lead encephalopathy. , 1975, Journal of neuropathology and experimental neurology.
[165] W. Russell,et al. The Principles of Humane Experimental Technique , 1960 .
[166] J. Winn,et al. Brain , 1878, The Lancet.
[167] Bradley T. Hyman,et al. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease , 2014, Acta Neuropathologica.
[168] C. Goodman,et al. Palliative and end-of-life care research in neurodegenerative diseases: Report of the JPND Action Group , 2014 .
[169] C. I. Fernández-Verdecia,et al. [Does Alzheimer's disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications (II)]. , 2014, Neurologia.
[170] Patrizia Mecocci,et al. A review of the major vascular risk factors related to Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[171] P. Sandøe,et al. Animal Models of Dementia: Ethical Considerations , 2011 .
[172] P. Deyn,et al. Animal Models of Dementia , 2011, Neuromethods.
[173] Jans H. Alzate-Morales,et al. Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[174] George Roth,et al. Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus). , 2006, Journal of Alzheimer's disease : JAD.
[175] J. Lamb,et al. Characterisation of the binding of amyloid imaging tracers to rodent Abeta fibrils and rodent-human Abeta co-polymers. , 2006, Biochemical and biophysical research communications.
[176] Philipp Khaitovich,et al. Human brain evolution. , 2006, Progress in brain research.
[177] J R Hodges,et al. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. , 2004, Journal of neurology, neurosurgery, and psychiatry.
[178] D. Holtzman,et al. Alzheimer A beta vaccination of rhesus monkeys (Macaca mulatta). , 2004, Alzheimer disease and associated disorders.
[179] S. Shankar,et al. Low-calcium, high-aluminum diet-induced motor neuron pathology in cynomolgus monkeys , 2004, Acta Neuropathologica.
[180] M. Tuszynski,et al. Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease. , 2004, Progress in brain research.
[181] T. Kemper,et al. The cytoarchitectonic distribution of senile plaques in three aged monkeys , 2004, Acta Neuropathologica.
[182] D. Holtzman,et al. Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta). , 2004, Mechanisms of ageing and development.
[183] D. Selkoe,et al. Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet. , 2004, The American journal of pathology.
[184] Alan Peters,et al. Structural changes in the normally aging cerebral cortex of primates. , 2002, Progress in brain research.
[185] P. S. St George-Hyslop,et al. Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis. , 2002, Nature medicine.
[186] P. S. St George-Hyslop,et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. , 2000, Nature.
[187] J. Hardy,et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. , 2000, Nature.
[188] D. Selkoe,et al. Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice. , 2000, Annals of the New York Academy of Sciences.
[189] M. Voytko,et al. Nonhuman primates as models for aging and Alzheimer's disease. , 1998, Laboratory animal science.
[190] M. Beal,et al. The neurotoxicity of amyloid beta protein in aged primates. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[191] Y. Miyashita,et al. The neuronal basis of visual memory and imagery in the primate: a neurophysiological approach. , 1998, Advances in biophysics.
[192] C. Geula,et al. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. , 1998, Nature medicine.
[193] J. Tigges,et al. beta-Amyloid (A beta) deposition in the brains of aged orangutans. , 1997, Neurobiology of aging.
[194] H. Mori,et al. Characterization of amyloid beta protein species in cerebral amyloid angiopathy of a squirrel monkey by immunocytochemistry and enzyme-linked immunosorbent assay. , 1997, Brain research.
[195] L. Walker,et al. Animal models of cerebral beta-amyloid angiopathy. , 1997, Brain research. Brain research reviews.
[196] R. Schiffer,et al. Incorrect diagnosis of Alzheimer's disease. A clinicopathologic study. , 1996, Archives of neurology.
[197] M. Gearing,et al. Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease. , 1996, Annals of neurology.
[198] J. Tigges,et al. A beta40 is a major form of beta-amyloid in nonhuman primates. , 1996, Neurobiology of aging.
[199] A. Calenda,et al. beta-Amyloid protein precursor in Microcebus murinus: genotyping and brain localization. , 1996, Neurobiology of disease.
[200] J. Gulcher,et al. Molecular evolution of tau protein: implications for Alzheimer's disease. , 1996, Journal of neurochemistry.
[201] A. Delacourte,et al. Immunocytochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus. , 1995, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[202] L. Walker,et al. beta-Amyloid precursor protein gene in squirrel monkeys with cerebral amyloid angiopathy. , 1995, Neurobiology of aging.
[203] A. Smith,et al. The diagnosis of Alzheimer's disease: a question of image? , 1994, The Journal of clinical psychiatry.
[204] H. Cooke,et al. Encyclopedia of human evolution and prehistory , 1991 .